Life-Saving Medicines, Rising Costs, and the Common Man’s Struggle

India is steadily moving forward with the dream of becoming a developed nation. The vision of a “Developed India” by 2047 is being reiterated time and again. Amid claims of massive infrastructure growth, digital transformation, remarkable space achievements, and economic progress, a fundamental question continues to arise: Can a nation truly be called developed if ordinary citizens are forced into debt because of illness? If the ever-increasing cost of medicines and medical treatment determines the thin line between life and death? If healthcare becomes a privilege of economic capacity rather than a basic right? At a time when inflation is already burdening common households, the decision of the National Pharmaceutical Pricing Authority (NPPA) to permit significant price hikes in certain life-saving medicines and vaccines has become a matter of serious concern. The approval of price increases—reportedly reaching nearly fifty percent for some cancer drugs, anti-tetanus serum, and essential childhood vaccines—has created a new crisis for millions of families. This issue is not merely economic; it raises profound questions about social justice, human compassion, and the very concept of a welfare-oriented state.

The reality of healthcare in India is well known. Government data indicate that a substantial proportion of citizens continue to bear medical expenses out of their own pockets. Illness no longer remains solely a health crisis; it often transforms into an economic catastrophe. There was a time when people commonly fell into debt because of wedding expenses. Today, however, a serious illness can financially devastate an entire family. The treatment of cancer, heart disease, kidney ailments, and other complex medical conditions often demands lakhs of rupees. If the prices of life-saving medicines continue to rise, healthcare will become increasingly inaccessible for the poor and lower middle classes. The NPPA has justified these price revisions by citing rising production costs and the risk of shortages in the market. According to this argument, pharmaceutical companies may discontinue production if they cannot recover their costs, resulting in a lack of availability of essential medicines. While this reasoning may hold economic merit, an important question remains: Can life-saving medicines be treated like ordinary consumer goods? Should there not be a balance between reasonable profit and social responsibility in the healthcare sector?

Healthcare and education are the two most fundamental pillars of any civilized society. Unfortunately, both sectors in India have witnessed growing commercialization over the years. Escalating hospital charges, expensive diagnostic tests, unnecessary medical investigations, high equipment costs, and now rising medicine prices are collectively making healthcare unaffordable for ordinary citizens. Medical care increasingly appears to be transforming from a service into an industry. Hospitals often seem more like corporate enterprises than centers of healing. Patients are frequently viewed as customers rather than individuals seeking care. This trend not only widens economic inequality but also deepens social divisions. Even today, quality healthcare remains largely accessible to those with stronger financial resources. Poor citizens are left dependent on overcrowded government hospitals with limited infrastructure and resources, while affluent individuals can afford advanced treatment in state-of-the-art private facilities. Is this the social justice envisioned by the nation’s founders? Is this the India that the freedom fighters dreamed of building?

Under the leadership of Prime Minister Narendra Modi, several welfare-oriented initiatives have been introduced. Schemes such as Ayushman Bharat have provided relief to millions, while the establishment of Jan Aushadhi Kendras has improved access to affordable medicines. Nevertheless, significant structural challenges continue to persist in the healthcare system. If medicine prices continue to rise and private healthcare remains largely unregulated, the benefits of these initiatives may be substantially diluted. The real challenge lies in placing healthcare at the center of public welfare rather than leaving it entirely to market forces. The government's responsibility extends beyond announcing schemes; it must also ensure that every citizen has access to affordable and quality healthcare. Stronger price controls on life-saving medicines are essential. Government hospitals must be adequately supplied with essential drugs. Procurement systems should be transparent and accountable. The government can also provide targeted subsidies and support for the production of critical medicines so that the burden of rising costs does not fall entirely on patients.

At the same time, health insurance coverage must be expanded significantly. Millions of poor and lower-middle-class families remain outside the protection of any meaningful insurance framework. A major illness can wipe out their lifetime savings. Health insurance should not be limited to hospitalization expenses alone; it should also cover essential medicines and long-term treatments. Furthermore, the government should periodically conduct independent reviews of pharmaceutical pricing and cost structures. If production costs have genuinely increased, the evidence should be publicly disclosed. Greater transparency would strengthen public trust and help prevent unjustified price escalation. The primary objective of healthcare policy should be to strike a fair balance between corporate profitability and citizens’ rights. The vision of a developed India in 2047 cannot be measured solely through skyscrapers, expressways, digital networks, or GDP growth. Its true success will be judged by the well-being of its most vulnerable citizens. If a farmer, laborer, employee, or low-income worker cannot access dignified medical treatment during illness, claims of development will remain incomplete.

The need of the hour is not merely a debate on medicine prices but a comprehensive reassessment of the entire healthcare system. Healthcare is not a luxury; it is a fundamental human right. In a nation where citizens are denied the opportunity to live healthy lives, the glow of economic progress inevitably fades. It is time for governments, policymakers, medical professionals, pharmaceutical companies, and society at large to work together to ensure that healthcare remains an instrument of public service rather than merely a source of profit. Otherwise, the dream of a developed India may shine brightly in statistics while millions continue to struggle in the darkness of illness, debt, and helplessness. As India moves toward the centenary of its independence, this remains one of its greatest moral and humanitarian challenges—one that demands urgent and meaningful solutions today.